Effects of multiple intrathecal administration of L-arginine with different doses on formalin-induced nociceptive behavioral responses in rats

Neuroscience Bulletin

Volumn 26, Issue 3, 2010, Pages 211-218

  Li, Kuan ^a   Qi, Wen Xiu ^a  

^a SHANXI MEDICAL UNIVERSITY   (China)

Author keywords

C fos; Formalin test; Genes; L arginine; Nitric oxide; Nitric oxide synthase; Pain; Spinal cord

Indexed keywords

ARGININE; FORMALDEHYDE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROTEIN C FOS; SODIUM CHLORIDE; CENTRAL NERVOUS SYSTEM AGENTS; NEURONAL NITRIC OXIDE SYNTHASE; NOS1 PROTEIN, RAT;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; BITE; CELL COUNT; CONTROLLED STUDY; DOSE RESPONSE; DOWN REGULATION; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG MECHANISM; DRUG MEGADOSE; EVOKED RESPONSE; FEMALE; GENE EXPRESSION REGULATION; IMMUNOCYTOCHEMISTRY; LICKING; LOW DRUG DOSE; MALE; NOCICEPTION; NONHUMAN; PROTEIN EXPRESSION; SPINAL CORD DORSAL HORN; UPREGULATION; ANIMAL; CHEMICALLY INDUCED; DRUG EFFECTS; HINDLIMB; IMMUNOHISTOCHEMISTRY; INTRASPINAL DRUG ADMINISTRATION; METABOLISM; MICROPHOTOGRAPHY; PAIN; PATHOLOGY; PHYSIOLOGY; POSTERIOR HORN CELL; RAT; SPRAGUE DAWLEY RAT; TIME;

ANIMALS; ARGININE; BEHAVIOR, ANIMAL; CELL COUNT; CENTRAL NERVOUS SYSTEM AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FORMALDEHYDE; HINDLIMB; IMMUNOHISTOCHEMISTRY; INJECTIONS, SPINAL; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE I; PAIN; PHOTOMICROGRAPHY; POSTERIOR HORN CELLS; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

EID: 77955939478     PISSN: 16737067     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12264-010-0127-9     Document Type: Article

References (25)

1. Kolesnikov YA, Chereshnev L, Criesta M, Pan YX, Pasternak GW. Opposing actions of neuronal nitric oxide synthase isoforms in formalin-induced pain in mice. Brain Res 2009, 1289: 14-21.
2. Célérier E, Ahdepil T, Wikander H, Berrendero F, Nyberg F, Maldonado R. Influence of the anabolic-androgenic steroid nandrolone on cannabinoid dependence. Neuropharmacology 2006, 50(7): 788-806.
3. Kawabata A, Manabe S, Takagi H. Comparison of antinociception induced by supraspinally administered L-arginine and kyotorphin. Br J Pharmacol 1994, 112(3): 817-822.
4. Kawabata A, Umeda N, Takagi H. L-Arginine exerts a dual role in nociceptive processing in the brain: involvement of the kyotorphin-Met- enkephalin pathway and NO-cyclic GMP pathway. Br J Pharmacol 1993, 109(1): 73-79.
5. Kawabata A, Manabe S, Manabe Y, Takagi H. Effect of topical administration of L-arginine on formalin-induced nociception in the mouse: a dual role of peripherally formed NO in pain modulation. Br J Pharmacol 1994, 112(2): 547-550.
6. Sousa AM, Prado WA. The dual effect of a nitric oxide donor in nociception. Brain Res 2001, 897(1-2): 9-19.
7. Chen LX, Qi YM, Wang R. Roles of nitric oxide synthase inhibitor on antinociceptive effects of μ-opioid agonist in mice. Protein Pept Lett 2006, 13(10): 993-997.
8. Coggeshall RE. Fos, nociception and the dorsal horn. Prog Neurobiol 2005, 77(5): 299-352.
9. Qi WX, Liu LX, Hao WC, Liang YG, Wang ML. Long-lasting application of L-Arg enhances the ability of learning and memory and nNOS or c-fos expression as well as the number of nerons in the cerebral cortex and hippocampus in rats. Chin J Neuroanat 2008, 24(4): 373-378.
10. Yaksh TL, Rudy TA. Chronic catheterization of the spinal subarachnoid space. Physiol Behav 1996, 17: 1031-1036.
11. Koch A, Zacharowski K, Boehm O, Stevens M, Lipfert P, von Giesen HJ, et al. Nitric oxide and pro-inflammatory cytokines correlate with pain intensity in chronic pain patients. Inflamm Res 2007, 56(1): 32-37.
12. Chu YC, Guan Y, Skinner J, Raja SN, Johns RA, Tao YX. Effect of genetic knockout or pharmacologic inhibition of neuronal nitric oxide synthase on complete Freund's adjuvant-induced persistent pain. Pain 2005, 119 (1-3): 113-123.
13. Chung E, Burke B, Bleber AJ, Doss JC, Ohgami Y, Quock RM. Dynorphin-mediated antinociceptive effects of L-arginine and SIN-1(an NO donor) in mice. Brain Res Bull 2006, 70(3): 245-250.
14. Ge ZJ, Tan YF, Zhao YP, Cui GX. Evidence that inhibition of spinal nitric oxide production contributes to the antinociceptive effects of emulsified isoflurane on formalin-induced pain in rats. Clin Exp Pharmacol Physiol 2008, 35(10): 1245-1251.
15. Sharma JN, Al-Omran A, Parvathy SS. Role of nitric oxide in inflammatory diseases. Inflammopharmacology 2007, 15(6): 252-259.
16. Muscoli C, Cuzzocrea S, Ndengele MM, Mollace V, Porreca F, Fabrizi F, et al. Therapeutic manipulation of peroxynitrite attenuates the development of opiate-induced antinociceptive tolerance in mice. J Clin Invest 2007, 17 (11): 3185-3187.
17. Tanabe M, Nagatani Y, Saitoh K, Takasu K, Ono H. Pharmacological assessments of nitric oxide synthase isoforms and downstream diversity of NO signaling in the maintenance of thermal and mechanical hypersensitivity after peripheral nerve injury in mice. Neuropharmacology 2009, 56(3): 702-708.
18. Madhusoodanan KS, Murad F. NO-cGMP signaling and regenerative medicine involving stem cells. Neurochem Res 2007, 32 (4-5): 681-694.
19. Zhang Y, Nie H, Wang H, Zhang RX, Qi JS, Qiao JT. C-fos antisense oligodeoxynucleotide decreases formalin-induced behavioral responses and both of the elevated c-Fos protein dynorphin A (1-8) expressions in the dorsal horn of juvenile rats. Chin J Neuroanat 2003, 19 (3): 243-250.
20. Yin JR, Wang W, Sun XD, Wu SX, Chai W. Effects of c-fos antisense oligodeoxynucleotides on inflammatory and neuropathic pain of rats. Chin J Neuroanat 2008, 24(4): 361-366.
21. Lima D, Avelino A. Spinal c-fos expression is differentially induced by brief or persistent noxious stimulation. Neuroreport 1994, 5(15): 1853-1856.
22. Fu KY, Zhang FY, Hou B, Yu YF, Ma XC, Zhang ZK. Neuronal apoptosis in the spinal dorsal horn in formalin pain animal model. Chin J Pain Med 2005, 11(1): 25-28.
23. Zimmermann M. Pathobiology of neuropathic pain. Eur J Pharmacol 2001, 429 (1-3): 23-37.
24. Kimura S, Hosaka N, Yuge I, Yamazaki A, Suda K, Taneichi H, et al. Cerebrospinal fluid concentrations of nitric oxide metabolites in spinal cord injury. Spine 2009, 34(18): 645-652.
25. Costa B, Siniscalco D, Trovato AE, Comelli F, Sotgiu ML, Colleoni M, et al. AM404, an inhibitor of anandamide uptake, prevents pain behaviour and modulates cytokine and apoptotic pathways in a rat model of neuropathic pain. Br J Pharmacol 2006, 148 (7): 1022-1032.